Alerts will be sent to your verified email
Verify EmailCTLLAB
|
Clinitech Laboratory
|
DhanvantriJeevan Rek
|
Dr Lalchandani Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.47 % | 2.68 % | 6.03 % |
|
5yr average Equity Multiplier
|
1.81 | 1.51 | 1.69 |
|
5yr Average Asset Turnover Ratio
|
1.31 | 1.22 | 0.43 |
|
5yr Avg Net Profit Margin
|
7.42 % | -1.83 % | 1.96 % |
|
Price to Book
|
0.0 | 0.9 | 0.0 |
|
P/E
|
21.68 | 73.4 | 19.67 |
|
5yr Avg Cash Conversion Cycle
|
-48.54 Days | 30.84 Days | 103.23 Days |
|
Inventory Days
|
10.56 Days | 2.65 Days | 78.71 Days |
|
Days Receivable
|
47.42 Days | 28.6 Days | 408.23 Days |
|
Days Payable
|
133.84 Days | -1976.44 Days | 262.63 Days |
|
5yr Average Interest Coverage Ratio
|
10.37 | 7.8 | 3.16 |
|
5yr Avg ROCE
|
22.56 % | -0.53 % | 5.08 % |
|
5yr Avg Operating Profit Margin
|
16.43 % | 2.35 % | 14.13 % |
|
5 yr average Debt to Equity
|
0.31 | 0.0 | 0.48 |
|
5yr CAGR Net Profit
|
-0.51 % | n/a | -16.1 % |
|
5yr Average Return on Assets
|
10.1 % | -0.6 % | 1.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
64.2 % | 19.65 % | 32.9 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.62 % | -0.12 % | -27.88 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Clinitech Laboratory
|
DhanvantriJeevan Rek
|
Dr Lalchandani Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|